Risk of fetal death after pandemic influenza virus infection or vaccination.Is there an association between SV40 contaminated polio vaccine and lymphoproliferative disorders? An age-period-cohort analysis on Norwegian data from 1953 to 1997.Combined administration of meningococcal serogroup B outer membrane vesicle vaccine and conjugated serogroup C vaccine indicated for prevention of meningococcal disease is safe and immunogenic.Persisting immune responses indicating long-term protection after booster dose with meningococcal group B outer membrane vesicle vaccineHuman antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccineMonitoring of timely and delayed vaccinations: a nation-wide registry-based study of Norwegian children aged < 2 years.Immunogenicity and safety of a combination of two serogroup B meningococcal outer membrane vesicle vaccines.Prevention of viral hepatitis in the Nordic countries and Germany.Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease.Neurological adverse events of immunization: experience with an aluminum adjuvanted meningococcal B outer membrane vesicle vaccine.Considerations for controlling invasive meningococcal disease in high income countries.Do selective immunisation against tuberculosis and hepatitis B reach the targeted populations? A nationwide register-based study evaluating the recommendations in the Norwegian Childhood Immunisation Programme.[A woman in her 40s with rash and spots on the oral mucosa].Susceptibility to cytomegalovirus, parvovirus B19 and age-dependent differences in levels of rubella antibodies among pregnant women.Design of clinical trials with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway.[Should school children receive pertussis vaccine?][Is vaccination dangerous?][Immediate allergic reactions to natural rubber][Adverse events after vaccination].The Norwegian meningococcal group B outer membrane vesicle vaccine: side effects in phase II trials.[Will a vaccine save us from SARS?].[Young children, pregnant women and travelling abroad].[Vaccination, inflammatory bowel disease and autism--is there a connection?]Q57104283Influenza vaccination in 22 developed countries: an update to 1995Influenza vaccination in 22 developed countries: an update to 1995Risk of Fetal Death After Pandemic Influenza Virus Infection or VaccinationResponse to third rubella vaccine dose
P50
Q30425981-12B99467-E697-4FD6-9608-B0F352970C42Q31018509-3166E537-F2A5-4E3D-AFD9-5F2E2D77D7B6Q33788581-FFE46B8E-943B-497D-8DE9-EA70B2EFB43FQ34720380-4B201063-2473-474C-9FA3-32F26FC2180BQ35454550-99F7AF63-16E2-42E2-91A8-C4B7B3C88C4EQ35840208-7A5BEB48-F7E2-4D2E-B59E-F367EE0283C4Q36095135-6C653F23-615E-43DA-8F6D-CFCD92F71125Q36229205-230ACECE-E4EB-4B1F-889A-3809FC080F8AQ36730825-55AE39C0-333E-4747-971F-6546705AEBA2Q36968308-5ECF56C5-E411-4F4A-9559-D781911F5C23Q38011317-CC1980C8-7D52-4490-B864-295B43A76450Q38395140-B621C6DF-3228-4904-AD86-F6EA4A421BE1Q40293899-11027FEE-3039-47E1-A432-14BB30EFDB5FQ42263388-90700F9F-AD39-4802-B971-CADC4C03272AQ43470693-8A6327D5-C97D-47DE-B01C-58CA0766B2F7Q43482478-AB44928D-02BF-42C4-BBEB-6DCC5987BCABQ44202977-0E124810-13CC-4637-9206-EE7C578F22A3Q44537305-C363B172-2437-48B4-88D9-B9BEFAAA4533Q44842805-AC202785-13A2-4F0F-BF6B-C0458F7F3426Q45202078-3030B0AC-607B-471B-A70F-C0F7E86F3424Q45289314-AE30DBFE-5619-4587-B97B-CC203671A2CCQ47908220-B995FBA1-A141-41F1-ADAD-94837722E1CFQ50310535-B5CA987D-D321-491C-B5E9-37BB9DD2FC5AQ57104283-F4067499-77BD-4EDA-AC9B-B3DE812CF69AQ57217341-F2599191-A608-4FBF-8DE4-9D6E19E6CF78Q57714367-24910F7B-9DF6-429E-A79C-5CCD4667913EQ61849126-4EC88E1C-8B70-46AC-A37F-11744839FBA5Q63430658-C0BB60E6-A13E-48E0-B6E0-A7B91D847317
P50
description
Noors arts
@nl
Norra arst
@et
Norwegian physician
@en
Norwegian physician
@en-ca
Norwegian physician
@en-gb
dochtúir Ioruach
@ga
doctoriță norvegiană
@ro
dokter asal Norwegia
@id
metgessa noruega
@ca
mjeke norvegjeze
@sq
name
Hanne Nøkleby
@ast
Hanne Nøkleby
@ca
Hanne Nøkleby
@de
Hanne Nøkleby
@en
Hanne Nøkleby
@es
Hanne Nøkleby
@fr
Hanne Nøkleby
@ga
Hanne Nøkleby
@nb
Hanne Nøkleby
@nl
Hanne Nøkleby
@sl
type
label
Hanne Nøkleby
@ast
Hanne Nøkleby
@ca
Hanne Nøkleby
@de
Hanne Nøkleby
@en
Hanne Nøkleby
@es
Hanne Nøkleby
@fr
Hanne Nøkleby
@ga
Hanne Nøkleby
@nb
Hanne Nøkleby
@nl
Hanne Nøkleby
@sl
altLabel
Hanne Nokleby
@nl
prefLabel
Hanne Nøkleby
@ast
Hanne Nøkleby
@ca
Hanne Nøkleby
@de
Hanne Nøkleby
@en
Hanne Nøkleby
@es
Hanne Nøkleby
@fr
Hanne Nøkleby
@ga
Hanne Nøkleby
@nb
Hanne Nøkleby
@nl
Hanne Nøkleby
@sl
P214
P106
P21
P213
0000 0003 6170 0898
P214
P2287
P27
P31
P569
1948-06-24T00:00:00Z
P734
P735
P7859
viaf-222238533